Tags

Type your tag names separated by a space and hit enter

Risks of oral contraceptive use in women over 35.
J Reprod Med. 1993 Dec; 38(12 Suppl):1030-5.JR

Abstract

Oral contraceptives are a reliable and convenient method of birth control. Nevertheless, physicians are reluctant to use them in women over 35 because of concerns about increased risks of cardiovascular disease, stroke and cancer despite evidence to the contrary. Well-designed studies have shown that the incidence of thromboembolic disease is related to the estrogen dose and that the risk of thromboembolism is highest in women who smoke. With current oral contraceptive formulations, there is no increased risk of cardiovascular disease or stroke in women without other risk factors. Oral contraceptives have been shown to protect against endometrial and ovarian cancer. The risk of breast cancer appears to be increased only minimally among current oral contraceptive users. Thus, oral contraceptives offer a safe and effective means of birth control in women over 35, especially in the absence of other risk factors.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, University of Washington, Seattle 98195.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8120860

Citation

Stenchever, M A.. "Risks of Oral Contraceptive Use in Women Over 35." The Journal of Reproductive Medicine, vol. 38, no. 12 Suppl, 1993, pp. 1030-5.
Stenchever MA. Risks of oral contraceptive use in women over 35. J Reprod Med. 1993;38(12 Suppl):1030-5.
Stenchever, M. A. (1993). Risks of oral contraceptive use in women over 35. The Journal of Reproductive Medicine, 38(12 Suppl), 1030-5.
Stenchever MA. Risks of Oral Contraceptive Use in Women Over 35. J Reprod Med. 1993;38(12 Suppl):1030-5. PubMed PMID: 8120860.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Risks of oral contraceptive use in women over 35. A1 - Stenchever,M A, PY - 1993/12/1/pubmed PY - 1993/12/1/medline PY - 1993/12/1/entrez KW - Age Factors KW - Americas KW - Biology KW - Breast Cancer KW - Cancer KW - Cardiovascular Effects KW - Contraception KW - Contraceptive Methods KW - Demographic Factors KW - Developed Countries KW - Diseases KW - Embolism KW - Endometrial Cancer KW - Europe KW - Family Planning KW - Literature Review KW - Neoplasms KW - North America KW - Northern America KW - Northern Europe KW - Oral Contraceptives KW - Ovarian Cancer KW - Physiology KW - Population KW - Population Characteristics KW - Risk Factors KW - Thromboembolism KW - United Kingdom KW - United States KW - Vascular Diseases SP - 1030 EP - 5 JF - The Journal of reproductive medicine JO - J Reprod Med VL - 38 IS - 12 Suppl N2 - Oral contraceptives are a reliable and convenient method of birth control. Nevertheless, physicians are reluctant to use them in women over 35 because of concerns about increased risks of cardiovascular disease, stroke and cancer despite evidence to the contrary. Well-designed studies have shown that the incidence of thromboembolic disease is related to the estrogen dose and that the risk of thromboembolism is highest in women who smoke. With current oral contraceptive formulations, there is no increased risk of cardiovascular disease or stroke in women without other risk factors. Oral contraceptives have been shown to protect against endometrial and ovarian cancer. The risk of breast cancer appears to be increased only minimally among current oral contraceptive users. Thus, oral contraceptives offer a safe and effective means of birth control in women over 35, especially in the absence of other risk factors. SN - 0024-7758 UR - https://www.unboundmedicine.com/medline/citation/8120860/Risks_of_oral_contraceptive_use_in_women_over_35_ L2 - https://medlineplus.gov/breastcancer.html DB - PRIME DP - Unbound Medicine ER -